Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2024-01-18
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Liking, Acceptability and Health Benefits of Grain Products
NCT01403857
Whole Grains, Gastric Emptying and Glycemic Response
NCT03467659
Grains Reduce Adiposity and Improve Nutrition Study
NCT00924521
Effects of Whole Grain on Weight Maintenance
NCT01239147
The Influence of Daily Intake of Whole Grain Barley or Oats on Biomarkers of Cardiovascular Disease
NCT01293604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group 1 - High Whole Grain, Low Sugar 6 servings of whole grain and \<13% energy from added sugars.
Group 2 - Low Whole Grain, Low Sugar 3 servings of whole grain and \<13% energy from added sugars.
Group 3 - High Whole Grain, High Sugar 6 servings of whole grain and \>13% energy from added sugars.
Group 4 - Low Whole Grain, High Sugar 3 servings of whole grain and \>13% energy from added sugars.
Detailed Study Design
The study measures and timing are outlined in the following table:
Screening Week 1 Baseline Week 2 Week 5 Week 8 Week 11 Week 14 Fasting Blood X X X XX MTT X X X Weight X X X X X X Body Composition X X CGM X X X Intake X Hedonics (palatability) X X X Appetite X X X Activity X X X Blood Pressure X X X X X X Microbiota X X X X X Compliance X X X X X MTT = Meal Tolerance Test; DXA= Dual-energy X-ray Absorptiometry; CGM=Continuous glucose monitoring
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Whole Grain, Low Sugar
6 servings of whole grain and \<13% energy from added sugars.
High Whole Grain, Low Sugar
6 servings of whole grain and \<13% energy from added sugars.
Low Whole Grain, Low Sugar
3 servings of whole grain and \<13% energy from added sugars.
Low Whole Grain, Low Sugar
3 servings of whole grain and \<13% energy from added sugars.
High Whole Grain, High Sugar
6 servings of whole grain and \>13% energy from added sugars.
High Whole Grain, High Sugar
6 servings of whole grain and \>13% energy from added sugars.
Low Whole Grain, High Sugar
3 servings of whole grain and \>13% energy from added sugars.
Low Whole Grain, High Sugar
3 servings of whole grain and \>13% energy from added sugars.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Whole Grain, Low Sugar
6 servings of whole grain and \<13% energy from added sugars.
Low Whole Grain, Low Sugar
3 servings of whole grain and \<13% energy from added sugars.
High Whole Grain, High Sugar
6 servings of whole grain and \>13% energy from added sugars.
Low Whole Grain, High Sugar
3 servings of whole grain and \>13% energy from added sugars.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prefer no use of medications, but if on medication, must have been on a stable dose for 3 months and plan to remain at the same dose for the duration of the trial.
* low customary intake of whole grain foods (less than 2 servings per day) and high energy from added sugar (greater than 10% energy).
Exclusion Criteria
* smoker
* intended weight loss or gain during the study period; intended change of activity level during the study period
* use of blood thinners
* prior gastrointestinal surgery.
21 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grain Foods Foundation
UNKNOWN
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Mattes
Distinguished Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Mattes, PhD
Role: PRINCIPAL_INVESTIGATOR
Purdue University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-2023-1071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.